Growth Metrics

Merck (MRK) Return on Capital Employed Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 726.00
Dec 31, 2025 1,608.00
Sep 30, 2025 1,164.00
Jun 30, 2025 1,114.00
Mar 31, 2025 1,269.00
Dec 31, 2024 1,319.00
Sep 30, 2024 208.00
Jun 30, 2024 255.00
Mar 31, 2024 -996.00
Dec 31, 2023 -978.00
Sep 30, 2023 -193.00
Jun 30, 2023 -89.00
Mar 31, 2023 942.00
Dec 31, 2022 783.00
Sep 30, 2022 1,260.00
Jun 30, 2022 1,123.00
Mar 31, 2022 1,106.00
Dec 31, 2021 1,210.00
Sep 30, 2021 -150.00
Jun 30, 2021 -359.00
Mar 31, 2021 -124.00
Dec 31, 2020 -3.00
Sep 30, 2020 -595.00
Jun 30, 2020 -662.00
Mar 31, 2020 -725.00
Dec 31, 2019 -849.00
Sep 30, 2019 1,089.00
Jun 30, 2019 984.00
Mar 31, 2019 816.00
Dec 31, 2018 514.00
Sep 30, 2018 372.00
Jun 30, 2017 -79.00
Mar 31, 2017 -128.00
Dec 31, 2016 -112.00
Sep 30, 2016 420.00
Jun 30, 2016 508.00
Mar 31, 2016 481.00
Dec 31, 2015 102.00
Sep 30, 2015 1,086.00
Jun 30, 2015 321.00
Mar 31, 2015 -182.00
Dec 31, 2014 -365.00
Sep 30, 2014 -5,370.00